Cimetidine Oral Solution is indicated for:
Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by cimetidine has been shown to be beneficial: persistent, dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Cimetidine Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Cimetidine Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Cimetidine Oral Solution
|Click here for Audio Version
|Peach and peppermint
|Do not store above 25°C
|Shelf Life (Closed Bottle/Open Bottle)
|18 months / 1 month
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.